96 related articles for article (PubMed ID: 9407431)
1. Why is proteinuria such an important risk factor for progression in clinical trials?
Jerums G; Panagiotopoulos S; Tsalamandris C; Allen TJ; Gilbert RE; Comper WD
Kidney Int Suppl; 1997 Dec; 63():S87-92. PubMed ID: 9407431
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
3. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
[TBL] [Abstract][Full Text] [Related]
4. New and old markers of progression of diabetic nephropathy.
Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
[TBL] [Abstract][Full Text] [Related]
5. Progression of diabetic nephropathy in type 1 diabetic patients.
Najafian B; Mauer M
Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384
[TBL] [Abstract][Full Text] [Related]
6. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.
Rosolowsky ET; Niewczas MA; Ficociello LH; Perkins BA; Warram JH; Krolewski AS
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S46-53. PubMed ID: 18849087
[TBL] [Abstract][Full Text] [Related]
7. Glomerular changes in normo- and microalbuminuric patients with long-standing insulin-dependent diabetes mellitus.
Fioretto P; Mauer M
Adv Nephrol Necker Hosp; 1997; 26():247-63. PubMed ID: 8922136
[TBL] [Abstract][Full Text] [Related]
8. Updating the natural history of diabetic nephropathy.
Pugliese G
Acta Diabetol; 2014 Dec; 51(6):905-15. PubMed ID: 25297841
[TBL] [Abstract][Full Text] [Related]
9. Albuminuric and non-albuminuric pathways to renal impairment in diabetes.
Macisaac RJ; Jerums G
Minerva Endocrinol; 2005 Sep; 30(3):161-77. PubMed ID: 16208306
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria: clinical signficance and basis for therapy.
Woo KT; Lau YK
Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
[TBL] [Abstract][Full Text] [Related]
11. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
12. Albuminuria and diabetic nephropathy.
Chang SS
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
Conti AA
Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
15. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
[TBL] [Abstract][Full Text] [Related]
16. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
17. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.
White KE; Marshall SM; Bilous RW
Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622
[TBL] [Abstract][Full Text] [Related]
19. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
Dalla Vestra M; Saller A; Mauer M; Fioretto P
J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
[TBL] [Abstract][Full Text] [Related]
20. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
